• 1
    Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med 1989; 321: 1648
  • 2
    Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol 1987; 137: 82936
  • 3
    Christ GJ. Penis as a vascular organ. Urol Clin North Am 1995; 22: 72747
  • 4
    Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 1984; 24: 17597
  • 5
    Moncado S. The L-arginine nitric oxide pathway. Acta Physiol Scand 1992; 145: 20127
  • 6
    Saenz de Tejada I, Blanco R, Goldstein I et al. Cholinergic neurotransmission in human corpus cavernosum I. Responses of isolated tissue. Am J Physiol 1988; 254: H46872
  • 7
    Azodzoi KM, Saenz de Tejada I. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1992; 148: 158791
  • 8
    Kim N, Azodzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic, noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991; 88: 1128
  • 9
    Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum on response to nonadrenergic-noncholinergic neurotransmission. N Engl J Med 1992; 326: 904
  • 10
    Bush PA, Aronson WJ, Buga GM, Rajfer J, Ignarro LJ. Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol 1992; 147: 16505
  • 11
    Bush PA, Aronson WJ, Rajfer J, Ignarro LJ. Comparison of nonadrenergic-noncholinergic and nitric oxide-mediated relaxation of corpus cavernosum. Int J Impot Res 1992; 4: 8593
  • 12
    McDulloch DK, Campbell CW, Prescott RJ, Clark BF. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279
  • 13
    Faerman I, Vilar O, Rivarola MA et al. Impotence and diabetes: studies of androgenic function in diabetic impotent males. Diabetes 1976; 25: 975
  • 14
    Faerman I, Glocer L, Fox D, Jadzinsky MN, Rapaport M. Impotence and diabetes: histological studies of autonomic nervous fibers of the corpora cavernosa in impotent males. Diabetes 1974; 23: 9716
  • 15
    Lincoln J, Crowe R, Blacklay PF, Pryor JP, Lumley JS, Burnstock G. Changes in VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and nondiabetic impotent males. J Urol 1987; 137: 10539
  • 16
    Saenz de Tejada I, Goldstein I, Azodzoi KM, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. New Engl J Med 1989; 320: 1025
  • 17
    Bemelsman BLH, Meulman EJH, Doesburg WH, Notermans SLH, Debruyne FMJ. Erectile dysfunction in diabetic men: the neurological factor revisited. J Urol 1994; 151: 8849
  • 18
    Gilman AG, Goodman LS, Gilman A Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 7th edn. New York: Macmillan Pub Co,1985; 66070
  • 19
    Ulrich P, Lazslo D, Bernd S, Rudi B. Selective inhibition of endothelium-dependent dilation in resistance sized vessels in vivo. Am J Physiol 1987; 253: H234
  • 20
    D’Orleans-Jusste P, Dion S, Mizrahi J, Regoli D. Effects of peptides and non-peptides on isolated arterial smooth muscle role of endothelium. Eur J Pharm 1985; 114: 9
  • 21
    Takahaski Y, Nobuhisa I, Lue TF, Tanagho EA. Effects of adenosine on canine erection. J Urol 1992; 148: 13235
  • 22
    Synder SH. Adenosine as a neuromodulator. Ann Rev Neurosci 1985; 8: 10324
  • 23
    Mey GD, Vanhoutte PM. Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries. J Physiol 1981; 316: 34755
  • 24
    Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-zaba J, Wells FC, Wallwork J. Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur Respir J 1990; 3: 6338
  • 25
    Dalziel HH, Westfall D. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev 1994; 46: 44966
  • 26
    Tong YC, Broderick G, Hypolite J, Levin RM. Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. Pharmacology 1992; 45: 2419
  • 27
    Mantelli R, Amerini S, Ledda F, Forth S, Maggi M. The potent relaxant effect of adenosine in rabbit corpora cavernosa is nitric oxide independent and mediated by A2 receptors. J Androl 1995; 16: 13127
  • 28
    Virag R, Adaikan PG. Effects of prostaglandin E1 on penile erection and erectile failure. J Urol 1987; 137: 1010
  • 29
    Roy AC, Tan SM, Kottegoda SR, Ratnam SS. Ability of human corpora cavernosa muscle to generate prostaglandins and thromboxanes in vitro. IRCS Med Sci 1984; 12: 6089
  • 30
    Jeremy JY, Morgan RJ, Mikhailidis DP, Dandona P. Prostacyclin synthesis by the corpora cavernosa of the human penis: evidence for muscarinic control and pathological implications. Prostaglandins Leukotrienes Med 1986; 23: 2116
  • 31
    Roy AC, Adaikan PG, Sen DK, Ratnam SS. Prostaglandin 15-hydroxydehydrogenase activity in human penile corpora cavernosa and its significance in prostaglandin-mediated penile erection. Br J Urol 1989; 64: 1802
  • 32
    Juenemann KP, Alken P. Pharmacotherapy of erectile dysfunction: a review. Int J Impotence Res 1989; 1: 7193
  • 33
    Hedlund H, Andersson KE. Contraction and relaxation induced by some prostanoids in isolated human penile erection tissue and cavernous artery. J Urol 1985; 134: 124550
  • 34
    Molderings GJ, Van Ahlen H, Porst H. Noradrenaline release in human corpus cavernosum by presynaptic prostaglandin receptors. Int J Impotence Res 1992; 4: 1926
  • 35
    Tesfamariam B, Jakubowski JA, Cohen RA. Contraction of diabetic rabbit aorta due to endothelium-derived PGH2 /TXA2 . Am J Physiol 1989; 257: H1327
  • 36
    Tesfamariam B, Brown B, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990; 85: 929
  • 37
    Chiang PH, Wu SN, Tsai EM et al. Adenosine modulation of neurotransmission in penile erection. Br J Clin Pharmacol 1994; 38: 35762
  • 38
    Ishii N. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence. J Urol 1989; 141: 3235
  • 39
    Sorosdy MF, Hundnall CH, Hardin TC et al. A prospective double blind trial of intracorporal papaverine versus prostaglandin E1 in the treatment of impotence. J Urol 1989; 141: 5513